[Lipid profile in untreated HIV positive patients. HIV infection: cardiovascular risk factor?]

B Baza Caraciolo1, C Pérez de Oteyza, D Carrió Montiel

  • 1Centro Sanitario Sandoval, IMSALUD Area 7 de la Comunidad de Madrid, Madrid, Spain. begobaza@gmail.com

Anales De Medicina Interna (Madrid, Spain : 1984)
|September 18, 2007
PubMed

Insights

HIV infection significantly alters lipid profiles, lowering HDL and ApoA1 levels, which increases cardiovascular risk (CVR) in untreated patients compared to HIV- individuals.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Biochemistry

Background:

  • HIV infection is increasingly linked to cardiovascular disease (CVD).
  • Understanding lipid profile changes in untreated HIV+ patients is crucial for assessing cardiovascular risk (CVR).

Purpose of the Study:

  • To characterize the lipid profile of untreated HIV+ individuals.
  • To compare lipid profiles between HIV+ and HIV- subjects.
  • To determine the influence of lipid abnormalities on CVR estimation in HIV+ patients.

Main Methods:

  • Analysis of lipid profiles (Total cholesterol, HDL, LDL, triglycerides, apolipoproteins) in 251 untreated HIV+ and 156 HIV- homosexual males.
  • Calculation of atherogenic rates (CHOL/HDL, LDL/HDL, log(TG/HDL)).
  • Classification of HIV+ patients based on CD4 lymphocyte counts.

Main Results:

  • HIV+ patients exhibited lower Total Cholesterol (CHOL), HDL-cholesterol (HDL), and Apolipoprotein A1 (ApoA1) levels compared to HIV- subjects.
  • Elevated CVR rates were observed in HIV+ patients.
  • A significant proportion (76%) of HIV+ patients had low HDL levels (<40 mg/dL) versus 31% in the HIV- group.

Conclusions:

  • Untreated HIV infection leads to distinct lipid profile alterations, including reduced HDL and ApoA1, persisting across all CD4 levels.
  • Decreased HDL levels in HIV-infected individuals significantly elevate overall CVR, independent of other risk factors.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...